GlassScriptPhysician profile
Brigid C Mccarthy
NPI 1912260753
$4,437.65
in general payments reported to CMS, 2019-2025
34 companies · $1,392 in 2025
The $1,392 reported for 2025 was more than what 97% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $626 · 2022: $821 · 2023: $757 · 2024: $841 · 2025: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,897 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,896.91 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $540.67 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $449.20 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $378.67 | 2025 | Voquezna |
| Sumitomo Pharma America, INC. | $296.86 | 2023-2025 | Myfembree, Gemtesa |
| Novo Nordisk INC | $256.16 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Therapeuticsmd, INC. | $200.31 | 2021-2022 | |
| Aspira Women'S Health INC | $185.90 | 2022-2023 | Ova1 |
| Exeltis, USA INC. | $175.46 | 2021-2025 | Slynd |
| Pfizer INC. | $160.07 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.31 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $150.85 | 2021-2024 | Airsupra |
| Merck Sharp & Dohme LLC | $144.42 | 2022-2024 | Gardasil 9, M-M-R II, Gardasil |
| Shield Therapeutics INC | $132.45 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $122.02 | 2025 | |
| Myovant Sciences INC. | $119.47 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.21 | 2022-2025 | Xifaxan |
| Exact Sciences Corporation | $95.35 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Dexcom, INC. | $76.05 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $74.18 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $68.55 | 2022-2025 | Shingrix, Bexsero, Jemperli |
| Lilly USA, LLC | $64.47 | 2021-2025 | Zepbound, Mounjaro |
| Coopersurgical, INC. | $62.86 | 2021-2023 | Paragard T 380a |
| Biogen, INC. | $52.18 | 2025 | Zurzuvae |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.89 | 2025 | Caplyta |
| Sanofi Pasteur INC. | $45.23 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $41.60 | 2021 | |
| Mayne Pharma Commercial LLC | $37.19 | 2021 | |
| Urovant Sciences INC | $34.49 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.05 | 2021 | |
| Amgen INC. | $30.06 | 2022-2023 | Repatha, Otezla |
| Organon LLC | $27.73 | 2022-2025 | Nexplanon |
| Seqirus USA INC | $23.71 | 2024 | Fluad, Flucelvax |
| Hologic Sales and Service, LLC | $17.19 | 2023 | Coolseal Generator |
| Sunovion Pharmaceuticals INC. | $16.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brigid Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.